Novonesis (Novozymes) B Logo

Novonesis (Novozymes) B (0Q4U)

LSE

Currency in DKK
445.55
-8.50 (-1.87%)

Real-time Data

07:00 AM

Day's Range

442.75
450.60

52 wk Range

337.50
457.50

Overview - 0Q4U - Novonesis (Novozymes) B

Key Statistics

Valuation

Enterprise Value

85.19B

P/E (Trailing)

‪36.16‬

P/E (Forward)

‪34.75‬

PEG Ratio

‪-1.91‬

Price / Sales (TTM)

‪6.95‬

Price / Book

‪9.22‬

EV / EBITDA

‪15.12‬

Profitability

Gross Margin

‪56.70%‬

Profit Margin

‪19.31%‬

Operating Margin

‪25.03%‬

Return on Assets

‪10.14%‬

Return on Equity

‪26.20%‬

Ownership

Shares Outstanding

466.22M

Float

194.75M

Held by Insiders

‪8.00%‬

Held by Institutions

‪40.45%‬

Price stats

Beta

‪0.44‬

50-Day Avg

‪414.46‬

200-Day Avg

‪393.89‬

Dividends

Payout Ratio

‪48.70%‬

Frequency

Annual

Market Cap - 0Q4U - Novonesis (Novozymes) B

Peers - 0Q4U - Novonesis (Novozymes) B

Peer Comparison

Compared with companies in Specialty Chemicals listed on LSE.

Profile Summary - 0Q4U - Novonesis (Novozymes) B

About

Novonesis (Novozymes) B is the Class B share of Novonesis A/S, a leading biotechnology company headquartered in Lyngby, Denmark. Formed in 2024 through the merger of Novozymes and Chr. Hansen, it holds a dominant near-50% market share in industrial enzymes and microbial solutions worldwide. The company develops and…

SectorBasic Materials
IndustrySpecialty Chemicals
Employees6.38K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.